Cargando…
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation
Mutations of the mitochondrial genome (mtDNA) cause a range of profoundly debilitating clinical conditions for which treatment options are very limited. Most mtDNA diseases show heteroplasmy – tissues express both wild-type and mutant mtDNA. While the level of heteroplasmy broadly correlates with di...
Autores principales: | Chung, Chih-Yao, Singh, Kritarth, Kotiadis, Vassilios N., Valdebenito, Gabriel E., Ahn, Jee Hwan, Topley, Emilie, Tan, Joycelyn, Andrews, William D., Bilanges, Benoit, Pitceathly, Robert D. S., Szabadkai, Gyorgy, Yuneva, Mariia, Duchen, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568893/ https://www.ncbi.nlm.nih.gov/pubmed/34737295 http://dx.doi.org/10.1038/s41467-021-26746-2 |
Ejemplares similares
-
MELAS and Kearns–Sayre overlap syndrome due to the mtDNA m. A3243G mutation and large-scale mtDNA deletions
por: Yu, Nian, et al.
Publicado: (2016) -
Segregation of mtDNA Throughout Human Embryofetal Development: m.3243A > G as a Model System
por: Monnot, Sophie, et al.
Publicado: (2011) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
por: Grady, John P, et al.
Publicado: (2018) -
The non-syndromic clinical spectrums of mtDNA 3243A>G mutation
por: Shen, Xiya, et al.
Publicado: (2021)